We are new pharmaceutical company established on the basis of experience of pharmaceutical, medical and financial experts with support of capital from financial institutions and financial market investors.

We plan to develop broad pharmaceutical activity comprising drugs of scientifically and clinically confirmed value.

We would like to introduce to the market generic plus drugs, well known and verified molecules used in new idications, new formulations or offered as OTC drugs previously used only as Rx.